tiprankstipranks
co.don AG (GB:0Q37)
LSE:0Q37

co.don AG (0Q37) Share Price & Analysis

0 Followers

0Q37 Stock Chart & Stats

Day’s Range€0 - €0
52-Week Range€0.03 - €0.03
Previous Close€0.03
Volume0.00
Average Volume (3M)N/A
Market Cap
€440.94K
Enterprise Value€5.05M
Total Cash (Recent Filing)€1.70M
Total Debt (Recent Filing)€6.30M
Price to Earnings (P/E)N/A
Beta2.77
Apr 26, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
Standard Deviation0.21
R-Squared0.00503
Alpha-0.00291
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

0Q37 FAQ

What was co.don AG’s price range in the past 12 months?
co.don AG lowest share price was €0.03 and its highest was €0.03 in the past 12 months.
    What is co.don AG’s market cap?
    Currently, no data Available
    When is co.don AG’s upcoming earnings report date?
    co.don AG’s upcoming earnings report date is Apr 26, 2024 which is tomorrow.
      How were co.don AG’s earnings last quarter?
      Currently, no data Available
      Is co.don AG overvalued?
      According to Wall Street analysts co.don AG’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does co.don AG pay dividends?
        co.don AG does not currently pay dividends.
        What is co.don AG’s EPS estimate?
        co.don AG’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does co.don AG have?
        co.don AG has 26,723,358 shares outstanding.
          What happened to co.don AG’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of co.don AG?
          Currently, no hedge funds are holding shares in GB:0Q37
          ---

          Company Description

          co.don AG

          Codon AG develops, produces and distributes autologous cell therapies for the minimally invasive repair of cartilage defects. The product being marketed is a cell therapy product for the minimally invasive treatment of cartilage damage in the knee joint that uses only the patient's own cartilage cells (autologous chondrocytes). CODON's method is currently used in over 200 clinics in Germany and more than 14,000 patients have already been treated.
          ---
          Similar Stocks
          Company
          Price & Change
          Follow
          BioNTech SE
          National Graphite
          Sangui BioTech International
          Popular Stocks
          ---
          What's Included in PREMIUM?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis